Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this clinical trial is to evaluate the change in the International
Prostate Symptom Score (IPSS) total score from the beginning of the study to the end of the
study for subjects randomized to tadalafil 5mg once a day dosing and placebo once a day
dosing for 12 weeks of treatment.